Using Botulinum Toxin to Treat Motor Neuron Diseases
Author Information
Author(s): Drachman Daniel B., Adams Robert N., Balasubramanian Uma, Lu Yang
Primary Institution: Johns Hopkins School of Medicine
Hypothesis
Can a fusion protein of botulinum toxin and streptavidin effectively deliver therapeutic genes to motor neurons?
Conclusion
The engineered fusion proteins can bind to motor neurons and potentially enhance gene delivery for treating ALS and SMA.
Supporting Evidence
- The fusion proteins can bind to motor neurons and other neuronal cell lines.
- Both ends of the fusion proteins are functionally intact.
- The strategy aims to improve the delivery of therapeutic genes to motor neurons.
Takeaway
Scientists are trying to use a special protein to help deliver medicine directly to the nerve cells that are sick in diseases like ALS.
Methodology
The study involved engineering fusion proteins of botulinum toxin and streptavidin to facilitate the delivery of biotinylated viral vectors to motor neurons.
Limitations
The study is still a work in progress and further research is needed to establish the efficacy of the proposed strategy.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website